Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
77,997,170
-
Share change
-
-1,654,439
-
Total reported value
-
$362,688,397
-
Put/Call ratio
-
146%
-
Price per share
-
$4.65
-
Number of holders
-
126
-
Value change
-
-$32,337,869
-
Number of buys
-
57
-
Number of sells
-
63
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q4 2017
As of 31 Dec 2017,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,997,170 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, ABRAMS CAPITAL MANAGEMENT, L.P., Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, CLEARBRIDGE, LLC, NORGES BANK, RICE HALL JAMES & ASSOCIATES, LLC, FMR LLC, and AMERIPRISE FINANCIAL INC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.